A new three-dose vial presentation of the maternal RSV vaccine received prequalification from the World Health Organization (WHO) on Wednesday, unlocking large-scale distribution across lower-income countries. The decision enables global health alliances to introduce affordable immunisation during pregnancy, protecting newborns from severe respiratory disease. Respiratory syncytial virus (RSV) remains the second leading cause of infant […] Continue reading ->
African scientists, institutions and communities are helping advance the development of new TB vaccines. Governments must now work together to prepare national systems, secure fair pricing and ensure scientific progress leads to timely and equitable access. When I visited the University of Cape Town Lung Institute and the South African Tuberculosis Vaccine Initiative (SATVI) in […] Continue reading ->